Omnicell price target lowered to $36 from $44 at JPMorgan

JPMorgan analyst Anne Samuel lowered the firm’s price target on Omnicell (OMCL) to $36 from $44 and keeps a Neutral rating on the shares. While Omnicell’s long-term targeted financial algorithm is favorable at a mid-teens revenue growth rate and roughly 400 basis points of annual margin expansion from 2021, inflationary and macro pressures are weighing on the model near-term, resulting in more compressed growth in the near-term, the analyst tells investors in a research note.